BENVEGNU', LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.368
AS - Asia 5.213
EU - Europa 2.355
SA - Sud America 1.016
AF - Africa 882
OC - Oceania 82
Continente sconosciuto - Info sul continente non disponibili 37
Totale 19.953
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.811
SG - Singapore 1.575
CN - Cina 865
VN - Vietnam 694
BR - Brasile 608
HK - Hong Kong 568
IT - Italia 353
FI - Finlandia 280
FR - Francia 250
BD - Bangladesh 219
DE - Germania 210
IN - India 152
PL - Polonia 136
SE - Svezia 112
UA - Ucraina 105
IQ - Iraq 98
GB - Regno Unito 89
AR - Argentina 88
TR - Turchia 82
RU - Federazione Russa 76
SA - Arabia Saudita 65
PK - Pakistan 64
CA - Canada 63
NL - Olanda 57
PH - Filippine 57
JP - Giappone 56
AT - Austria 55
CO - Colombia 55
MX - Messico 53
UZ - Uzbekistan 50
ZA - Sudafrica 46
EC - Ecuador 43
ID - Indonesia 42
JM - Giamaica 41
IE - Irlanda 40
CI - Costa d'Avorio 39
NI - Nicaragua 37
VE - Venezuela 37
AZ - Azerbaigian 36
TH - Thailandia 36
CL - Cile 35
MY - Malesia 35
MD - Moldavia 34
PE - Perù 33
BO - Bolivia 32
CR - Costa Rica 32
GE - Georgia 32
LY - Libia 32
NP - Nepal 32
TN - Tunisia 32
AE - Emirati Arabi Uniti 31
AL - Albania 31
ET - Etiopia 31
KE - Kenya 31
GA - Gabon 30
JO - Giordania 30
PY - Paraguay 30
IL - Israele 29
LC - Santa Lucia 29
MA - Marocco 29
MK - Macedonia 29
UY - Uruguay 29
BJ - Benin 28
CV - Capo Verde 28
HN - Honduras 28
LV - Lettonia 28
ME - Montenegro 28
PR - Porto Rico 28
DZ - Algeria 27
KH - Cambogia 26
NO - Norvegia 26
PT - Portogallo 26
RS - Serbia 26
BB - Barbados 25
BZ - Belize 25
EG - Egitto 25
ES - Italia 25
GF - Guiana Francese 25
GR - Grecia 25
IR - Iran 25
KZ - Kazakistan 25
BF - Burkina Faso 24
LB - Libano 24
RO - Romania 24
AO - Angola 23
BY - Bielorussia 23
CY - Cipro 23
HR - Croazia 23
KR - Corea 23
MN - Mongolia 23
SN - Senegal 23
ZM - Zambia 23
BA - Bosnia-Erzegovina 22
LU - Lussemburgo 22
NZ - Nuova Zelanda 22
ZW - Zimbabwe 22
AF - Afghanistan, Repubblica islamica di 21
DO - Repubblica Dominicana 21
GN - Guinea 21
HU - Ungheria 21
Totale 18.958
Salva come PNG Salva come JPEG
Città #
Fairfield 1.150
Ashburn 1.077
Woodbridge 940
Singapore 937
San Jose 794
Houston 721
Jacksonville 524
Hong Kong 521
Ann Arbor 452
Wilmington 434
Seattle 423
Cambridge 374
Chandler 344
Ho Chi Minh City 209
Princeton 199
Boardman 181
Hanoi 179
Helsinki 129
Lauterbourg 120
San Diego 118
Santa Clara 110
Bytom 102
Beijing 99
Los Angeles 91
Roxbury 84
Medford 81
Guangzhou 76
Nanjing 73
New York 68
São Paulo 55
Baghdad 42
Des Moines 40
Orem 40
Tashkent 40
Padova 39
Abidjan 37
Managua 36
Council Bluffs 35
Rome 35
Baku 34
Tokyo 34
Milan 33
Vienna 33
Shanghai 32
Dublin 31
Munich 30
Amman 29
Nairobi 29
Castries 28
Libreville 28
Buffalo 27
Haiphong 27
Cotonou 26
Dong Ket 26
Podgorica 26
San José 26
Bridgetown 25
Changsha 25
Da Nang 25
Praia 25
Hebei 24
Tripoli 24
Chisinau 23
Dallas 23
Kingston 23
Addis Ababa 22
Dakar 22
Jeddah 22
Jiaxing 22
Lima 22
Phnom Penh 22
Ulan Bator 22
Bamako 21
Conakry 21
Harare 21
Lusaka 21
Nanchang 21
Norwalk 21
Riga 21
Tianjin 21
Tirana 21
Kingstown 20
Montevideo 20
Shenyang 20
Bangkok 19
Chicago 19
La Paz 19
Lahore 19
Minsk 19
Quito 19
Riyadh 19
Warsaw 19
Bogotá 18
Istanbul 18
Luanda 18
New Delhi 18
Panama City 18
Tbilisi 18
Cayenne 17
Dushanbe 17
Totale 12.422
Salva come PNG Salva come JPEG
Nome #
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 321
Significance of platelet and AFP levels and liver function parameters for HCC size and survival. 311
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 287
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 278
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 278
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 276
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: Clinical presentation, treatment and outcome 272
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 269
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 261
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 258
Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development. 252
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 244
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 240
Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. 234
Years of life that could be saved from prevention of hepatocellular carcinoma 233
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from 20-year multicentre experience in Italy 230
Prognosis of untreated hepatocellular carcinoma. 227
Role of transient elastography to stage fontan-associated liver disease (Fald) in adults with single ventricle congenital heart disease correction 219
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype 214
Restaging patients with hepatocellular carcinoma before additional treatment decisions: a multicenter cohort study 212
Laparoscopic microwave ablation in patients with hepatocellular carcinoma: A prospective cohort study 210
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma 209
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. 201
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group 201
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study 200
A randomized controlled trial of thymopentin therapy in patients with chronic hepatitis B 198
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 197
Alphafetoprotein and Transplant Survival Benefit For Patients With Hepatocellular Carcinoma: A Multicentre Cohort Study 195
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study 194
Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma 183
Hepatocellular carcinoma in patients with cryptogenic cirrhosis. 180
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA database 180
Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels 180
Parenchymal transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology 179
The changing scenario of hepatocellular carcinoma over the last two decades in Italy. 177
Cost-effectiveness of semiannual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer Population 177
Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis 177
Fibrosis progression in initially mild chronic hepatitis C 176
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma. 175
Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres. 175
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma. 174
Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. 172
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 171
Risk factors and prevention of hepatocellular carcinoma in HCV infection 170
Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma 169
Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications 168
Natural history of hepatitis C. 167
A Liver Index and its Relationship to Indices of HCC Aggressiveness 167
Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis. 166
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience 165
Hepatocellular carcinoma in patients without cirrhosis in Italy. 165
Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis 163
Incidence of post-transfusion hepatitis in relation to risk factor. Result of prospective studies and efficacy of preventive measures 162
Transarterial chemoembolization in Child-Pugh class B patients with hepatocellular carcinoma: between the devil and the deep blue sea 162
Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma. 160
Specificity and patterns of antibodies to hepatitis C virus in hepatocellular carcinoma. 159
Natural history of initially mild chronic hepatitis C. 158
Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study. 158
Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival. 156
Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis? 155
Antibodies to hepatitis C virus in hepatocellular carcinoma. 154
Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. 153
Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effcts on cancer stage and patients survival (Italian experience) 148
Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma 148
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? 147
Therapy of acute hepatitis C 145
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. 145
Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. 144
Prevalence of Liver Disease in a Population of Asymptomatic Persons with Hepatitis C Virus Infection 143
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study 141
Ten-year outcome of radiofrequency thermal ablation for hepatocellular carcinoma: an italian experience. 141
A scoring system to predict the risk of hepatocellular carcinoma (HCC) in patients with compensated cirrhosis. 140
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 140
Relative decrease in the role played by hepatitis B virus infection in the aetiology of hepatocellular carcinoma during a 20-year period: a multicentre Italian study 140
Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? 138
Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters. 137
Coinfection by hepatitis B virus and hepatitis C virus. 135
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance 135
Space-occupyng lesions of the liver detected by ultrasonography and their relation to hepatocellular carcinoma in cirrhosis 134
Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. 133
CHRONIC HEPATITIS C WITHOUT ANTIBODY TO C-100 132
RESPONSE TO RIBAVIRIN, TO INTERFERON AND TO A COMBINATION OF BOTH IN PATIENTS WITH CHRONIC HEPATITIS C AND ITS RELATION TO HCV GENOTYPES 131
Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. 131
HEPATITIS C VIRUS INFECTION AND REPLICATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA 129
Early detection of hepatocellular carcinoma in patients with cirrhosis by alfa-fetoprotein, ultrasound and fine needle biopsy. 128
IL RISCHIO DI EPATOCARCINOMA E'MAGGIORE NELLA CIRROSI DA HBV RISPETTO ALLA CIRROSI DA HCV 126
Long-term clinical outcome after beta-interferon therapy in cirrhotic patients with chronic hepatitis C. TVVH Study Group 126
STORIA NATURALE DELLA INFEZIONE DA HCV: DALL’INFEZIONE ACUTA ALL’INFEZIONE CRONICA 123
Low alpha-fetoprotein HCC and the role of GGTP. 123
Oxford textbook of hepatology 122
HEPATITIS C: DIAGNOSIS AND THERAPY 118
COMPARISON OF DIFFERENT TYPES AND DOSES OF ALPHA IFN FOR TREATMENT OF CHRONIC HEPATITIS C 117
RESPONSE TO RIBAVIRIN, TO INTERFERON AND TO A COMBINATION OF BOTH IN PATIENTS WITH CHRONIC HEPATITIS C AND ITS RELATION TO HCV GENOTYPES 114
Management of hepatitis C 113
CHARACTERIZATION OF HUMAN HEPATOCYTE RECEPTORS FOR HEPATIITS B VIRUS ENVELOPE PROTINS 111
HEPATITIS B VIRUS AND PRIMARY HEPATIC TUMORS IN ITALIAN CHILDREN 111
HEPATITIS B VIRUS AND PRIMARY HEPATIC TUMORS IN ITALIAN CHILDREN 111
The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease 111
SERUM LEVELS OF HEPATITIS B VIRUS (HBV) PRE S1 PROTEIN DETECTED BY QUANTITATIVE ELISA 110
Different patterns of hepatocellular carcinoma development in cirrhosis associated with hepatitis B virus and hepatitis C virus: a long-term prospective study 104
Totale 17.399
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.207
article - articoli 47.496
book - libri 314
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.539
Totale 105.556
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.484 24 204 201 109 43 48 124 148 68 33 190 292
2022/2023855 242 40 17 83 161 101 12 53 84 4 49 9
2023/2024429 26 50 45 25 20 29 15 12 16 48 59 84
2024/20252.131 3 123 103 44 272 43 61 147 238 83 444 570
2025/20269.464 214 801 1.404 1.452 759 384 1.088 982 1.042 548 304 486
2026/2027280 280 0 0 0 0 0 0 0 0 0 0 0
Totale 20.023